Using 18F-FDG PET/CT (FDG PET/CT) for systemic staging of patients with newly diagnosed stage III breast cancer may not be useful, according to a study presented at the American Roentgen Ray Society (ARRS) 2015 Annual Meeting in Toronto, Canada. {read more here}

Increased overall survival and a longer time before tumor recurrence is associated with low presurgery uptake of a labeled glucose analogue, a marker of metabolic activity, in the primary tumor of patients with stage I non-small cell lung cancer (NSCLC). Patients with high uptake of labeled glucose may benefit from additional therapy following surgery. {read more here}

Patients with early-stage Hodgkin’s lymphoma who receive negative findings on PET following three cycles of chemotherapy have a very good prognosis whether or not they received follow up radiotherapy, according to the U.K.-based RAPID trial. {read more here}

It’s long been known that people with Down syndrome are at higher risk for Alzheimer’s disease.  Now, research suggests that changes in the brains of people with Down syndrome, as seen on brain scans, might help lead to promising treatments that could delay or prevent Alzheimer’s. {read more here}